Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

(2019) Connie B. Newman et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

(2019) Jane Armitage et al.   LANCET

N-terminal pro B-Type natriuretic peptide is inversely correlated with low density lipoprotein cholesterol in the very elderly

(2018) F. Spannella et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

A longitudinal 20 years of follow up showed a decrease in the survival of heart failure patients who maintained low LDL cholesterol levels

(2018) G Charach et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

OUP accepted manuscript

(2018)   EUROPEAN HEART JOURNAL

Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial

(2017) Nobuhisa Hagiwara et al.   EUROPEAN HEART JOURNAL

Effect of PCSK9 Inhibitors on Clinical Outcomes in Patients With Hypercholesterolemia: A Meta‐Analysis of 35 Randomized Controlled Trials

(2017) Aris Karatasakis et al.   Journal of the American Heart Association

Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes

(2017) Marshall B. Elam et al.   JAMA Cardiology

Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA)

(2016) Fizza Arain et al.   BIOMARKERS

Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin TherapyCLINICAL PERSPECTIVE

(2016) Ian Ford et al.   CIRCULATION

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

(2016) Alberico L. Catapano et al.   EUROPEAN HEART JOURNAL

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN HEART JOURNAL

High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease

(2016) Ian Ford et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Interpretation of the evidence for the efficacy and safety of statin therapy

(2016) Rory Collins et al.   LANCET

The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials

(2015) David Preiss et al.   EUROPEAN HEART JOURNAL

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

(2015) Erik S. Stroes et al.   EUROPEAN HEART JOURNAL

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

(2015)   LANCET

Effect of Rosuvastatin on Repeat Heart Failure Hospitalizations

(2014) Jennifer K. Rogers et al.   JACC-Heart Failure

Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm

(2013) Jamie Robertson et al.   Nature Reviews Rheumatology

Long-Term Effects of Statin Treatment in Elderly People: Extended Follow-Up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)

(2013) Suzanne M. Lloyd et al.   PLoS One

Prognostic Significance of Serum Total Cholesterol and Triglyceride Levels in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)

(2012) Stephen J. Greene et al.   AMERICAN JOURNAL OF CARDIOLOGY

Serum total cholesterol: A mortality predictor in elderly hospitalized patients

(2012) Avraham Weiss et al.   CLINICAL NUTRITION

N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS

(2012) P. Welsh et al.   EUROPEAN HEART JOURNAL

Low Serum Cholesterol as Prognostic Indicator in Heart Failure

(2012) Ijeoma Ananaba et al.   JOURNAL OF CARDIAC FAILURE

Low Serum Total Cholesterol Level is a Surrogate Marker, But Not a Risk Factor, for Poor Outcome in Patients Hospitalized With Acute Heart Failure: A Report From the Korean Heart Failure Registry

(2012) Chang-Hwan Yoon et al.   JOURNAL OF CARDIAC FAILURE

The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the UK

(2011) Peter S. Sever et al.   EUROPEAN HEART JOURNAL

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

(2011) et al.   EUROPEAN HEART JOURNAL

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis

(2011)   EUROPEAN HEART JOURNAL

Efficacy of statin therapy in chronic systolic cardiac insufficiency: A meta-analysis

(2011) Shuning Zhang et al.   European Journal of Internal Medicine

Effects of Statin Treatment on Cardiac Function in Patients With Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials

(2010) Lei Zhang et al.   CLINICAL CARDIOLOGY

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

(2009) John J.V. McMurray et al.   CIRCULATION

High-density Lipoprotein Cholesterol Levels and Prognosis in Advanced Heart Failure

(2009) Mandeep R. Mehra et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin

(2009) John G.F. Cleland et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure

(2008) Tamara B. Horwich et al.   AMERICAN HEART JOURNAL

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

(2008) GISSI-HF investigators   LANCET

Cholesterol — A marker of nutritional status in mild to moderate heart failure

(2007) José Paulo Araújo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY